US CBD Product Security and Standardization Invoice Launched

A bipartisan bill setting federal standards for CBD food and beverage products was tabled in the US last week.

US Representatives Kathleen Rice, Morgan Griffith, Angie Craig and Dan Crenshaw presented the draft “CBD Product Safety and Standardization Act of 2021” in response to the FDA’s hesitation in introducing regulations.

“CBD products are becoming increasingly popular, but the lack of state regulation has put consumers at risk and has led companies to seek clarity,” said Representative Rice. “The bipartisan CBD Product Safety and Standardization Act will create the clear regulatory framework needed to ensure stability for the business and ensure unsafe products stay off the shelves.”

The bill is supported by the Consumer Brands Association and the US Hemp Roundtable.

“We strongly support the FDA’s need to regulate hemp extracts such as CBD as food and beverage ingredients,” said Jonathan Miller of the US Hemp Roundtable.

However, the organization said it supports “aspects” of the bill and is keen to work with its sponsors to ensure that the legislation “provides the broadest protection for hemp extract products for human and animal consumption”.

Many Americans still don’t know that there are no FDA regulations for cannabidiol, and the FDA has stated in the past that it needed more data to create it. In its Data Acceleration Plan (CDP-DAP) for Cannabis-Derived Products published in October, the FDA stated:

“Overall, the growth of the CDP market continues to outpace science and our understanding of the public health impact of these products.”

To make matters worse, in addition to cannabidiol, other cannabinoid markets derived from hemp are also growing; especially delta-8-tetrahydrocannabinol (delta-8 THC). Others include Delta-10-Tetrahydrocannabinol (Delta-10-THC), Cannabinol (CBN),
Tetrahydrocannabivarin (THCV) and cannabigerol (CBG).

But cannabidiol is well established in the U.S. and some would argue that the agency had plenty of time and data – more than enough of both to focus specifically on CBD – and needs a really solid boost now.

The full text of the proposed 2021 CBD Product Safety and Standardization Act can be viewed here.